Drug information for DORIBAX
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; IV (INFUSION)
250MG/VIAL
Prescription
DORIPENEM
doripenem
JANSSEN PHARMS
22106
2012-01-31 Label
2009-04-23 Label
2009-04-23 Label
2009-04-21 Letter
2009-04-21 Letter
2009-02-12 Label
2008-07-22 Summary Review
2008-03-14 Review
2007-10-22 Letter
2007-10-15 Label
INJECTABLE; IV (INFUSION)
500MG/VIAL
Prescription
(Reference Drug)
DORIPENEM
doripenem
JANSSEN PHARMS
"
Drug Adverse Effects information for DORIBAX
Role code
Indications
Reaction
# Reports
PS
ESCHERICHIA INFECTION
ANAPHYLACTIC SHOCK
1
PS
PNEUMONIA
ANURIA
1
PS
PNEUMONIA
BLOOD PRESSURE INCREASED
1
PS
PNEUMONIA
BRADYCARDIA
1
PS
PNEUMONIA
OXYGEN SATURATION DECREASED
2
PS
PNEUMONIA
Q FEVER
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD PRESSURE INCREASED
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
OXYGEN SATURATION DECREASED
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
Q FEVER
1
PS
SEPSIS
CONVULSION
4
SS
PNEUMONIA
ANURIA
1
SS
PNEUMONIA
BRADYCARDIA
1
SS
PNEUMONIA
OXYGEN SATURATION DECREASED
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
BRONCHOSPASM
8
SS
PRODUCT USED FOR UNKNOWN INDICATION
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
8
C
DIURETIC THERAPY
INTERSTITIAL LUNG DISEASE
1
C
HEPATITIS C
ASTHENIA
2
C
HEPATITIS C
BLOOD GLUCOSE INCREASED
2
C
HEPATITIS C
CHILLS
2
C
HEPATITIS C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
2
C
HEPATITIS C
CONSTIPATION
2
C
HEPATITIS C
COUGH
2
C
HEPATITIS C
CREPITATIONS
2
C
HEPATITIS C
DECREASED APPETITE
2
C
HEPATITIS C
DEHYDRATION
2
C
HEPATITIS C
DIZZINESS
2
C
HEPATITIS C
DYSPNOEA
2
C
HEPATITIS C
GAIT DISTURBANCE
2
C
HEPATITIS C
NAUSEA
2
C
HEPATITIS C
PLATELET COUNT DECREASED
2
C
HEPATITIS C
PNEUMONIA
2
C
HEPATITIS C
RESPIRATORY DISTRESS
2
C
HEPATITIS C
VOMITING
2
C
POLYURIA
BLOOD UREA INCREASED
1
C
POLYURIA
INTERSTITIAL LUNG DISEASE
1
C
POLYURIA
PULMONARY ALVEOLAR HAEMORRHAGE
1
C
PULMONARY ARTERIAL HYPERTENSION
DEVICE RELATED INFECTION
2
C
PULMONARY ARTERIAL HYPERTENSION
PYREXIA
2
Ads by Google